.custom-subheader { font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 17px; font-weight: 600; line-height: 1.5em; margin-top: 1.5em; margin-bottom: 1em; }
Skip to main content

The rockefeller university

News & HighlightsNews
Displaying 169 of 2939 articles.
Scientists trace severe COVID-19 to faulty genes and autoimmune condition
The findings explain why some people are so vulnerable to the infection, and suggest new avenues for treatment.
Microbes in the gut may influence metabolism
A growing number of studies find that microbes in the gut directly influence biological processes from bowel movements to behavior. New research reveals how they impact levels of glucose in the blood.
Scientists uncover antiviral protein that blocks coronavirus infection
New research identifies a protein that blocks infection by SARS-CoV-2, the coronavirus that causes COVID-19, along with several other types. The findings could inform treatment strategies and help us better prepare for future outbreaks.
Newly discovered anti-CRISPR protein gives viruses a leg up against bacteria
Molecular CRISPR-Cas systems, most commonly known for their usefulness as gene editing tools, are ancient defense mechanisms employed by bacteria against viruses. The discovery of a counteracting viral trick could inform scientists' efforts to develop future gene-editing technologies.
Will SARS-CoV-2 escape future drugs by mutating? The answer may be a nuanced “no.”

Scientists hope to deploy antibodies in the quest to end COVID-19. A recent study moves them closer to accomplishing a key step: finding out if the virus may acquire resistance to antibody-based drugs or vaccines, and how to potent...

How toothless mock viruses could advance research on COVID-19
Scientists have engineered four viruses resembling SARS-CoV-2 to enable faster and safer research on vaccines and treatments.
COVID-19 immunology study reveals universally effective antibodies

New findings characterize human antibody response to SARS-Cov-2, with implications for convalescent plasma therapy, vaccine design, and antibody-based drugs.

How antibodies from llamas may lead to COVID-19 treatment
Llamas make antibodies that are much smaller than their human counterparts, yet still potent. Scientists hope that future drugs based on these molecules could provide new weapons against SARS-CoV-2.
Study reveals first evidence inherited genetics can drive cancer’s spread
Scientists have long struggled to understand what drives a tumor to seed itself elsewhere in the body. New research implicates our own pre-existing genetics.
Rockefeller scientists investigate life-threatening inflammation affecting children with COVID-19
The condition resembles a rare childhood illness, Kawasaki disease. Researchers are analyzing blood samples to find genetic clues to what might be causing it.
View
View